PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2021SHILAP Revista de lepidopterología186 citationsOpen Access

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

DMDavide MelisiDODo‐Youn OhAHAntoine Hollebecque

Key Points

Key points are not available for this paper at this time.

Abstract

ClinicalTrials.gov identifier: NCT02734160.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Melisi et al. (2021) studied this question.

synapsesocial.com/papers/69dab4d7387cf706986876f2https://doi.org/10.1136/jitc-2020-002068
Ask AI
Helpful
Bookmark
Share
View Full Paper